| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |